Redo PCI or CABG, Left Main Patients Pay a Price: EXCEL Redo PCI or CABG, Left Main Patients Pay a Price: EXCEL
A new 3-year analysis shows that repeat revascularization is more common after PCI than bypass surgery, but durability remains an issue for both strategies.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 17, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Surveillance of surgical site infections in NHS hospitals in England: April 2018 to March 2019
Amongst other points, this report found ten year trends in surgical site infection (SSI) risk for hip replacement and CABG has decreased, but SSI rates from spinal surgery has increased. National benchmarks for inpatient and readmission-detected SSI have remain relatively stable. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 9, 2020 Category: Consumer Health News Source Type: news

Coronary Artery Bypass Graft (CABG)
Title: Coronary Artery Bypass Graft (CABG)Category: Procedures and TestsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/3/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 3, 2020 Category: Cardiology Source Type: news

NOBLE at 5 Years Supports CABG Over PCI in Left Main Disease NOBLE at 5 Years Supports CABG Over PCI in Left Main Disease
PCI offered early benefits but was inferior to surgery for major adverse cardiovascular or cerebrovascular events -- findings that may provide more fuel for the EXCEL controversy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 2, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Quantifying Heart Failure Using Natriuretic Peptides Quantifying Heart Failure Using Natriuretic Peptides
Might quantifying the presence and extent of cardiac hemodynamic stress and heart failure by using natriuretic peptides help in choosing between PCI or CABG for revascularization?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

PCI vs CABG in Left Main Disease -- The Surgeons Are Right PCI vs CABG in Left Main Disease -- The Surgeons Are Right
A claim of equivalence for stents vs surgery in patients with left main coronary artery disease was called into question at EACTS. John Mandrola, MD, takes a closer look at the EXCEL trial controversy.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2019 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news

Sparks, Accusations Fly Over Conduct of EXCEL Trial Sparks, Accusations Fly Over Conduct of EXCEL Trial
' What happened in EXCEL was a disgrace,'a noted surgeon said of the recent PCI vs CABG trial.'No one has any idea what he's talking about, and it is an outright falsehood,'said an EXCEL trialist.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 15, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Oct 11 2019 This Week in Cardiology Oct 11 2019 This Week in Cardiology
Left main PCI vs CABG trials and TAVR vs SAVR — in this week ’ s podcast, Dr John Mandrola takes a deeper dive.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 11, 2019 Category: Cardiology Tags: Cardiology Commentary Source Type: news

PCI, CABG for Left Main CAD Have Similar Five-Year Outcomes
FRIDAY, Oct. 4, 2019 -- Five-year rates of a composite outcome of death, stroke, and myocardial infarction are similar for patients with left main coronary artery disease following either percutaneous coronary intervention (PCI) or coronary artery... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2019 Category: Pharmaceuticals Source Type: news

EXCEL at 5 Years: PCI, CABG'Relatively Comparable' in LM Disease EXCEL at 5 Years: PCI, CABG'Relatively Comparable' in LM Disease
Which of PCI or CABG for left main disease better prevented death, MI, or stroke? One prevailed early on, the other after a few years. Overall, they matched. The clinical message has shades of gray.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 30, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Expert Alert: Study finds repeat coronary artery bypass grafting improves long-term survival
ROCHESTER, Minn. ?-- When a coronary artery bypass grafting (CABG) patient needs a second surgery because of recurrent chest pain, more often than not it's a percutaneous coronary intervention (PCI), commonly known as coronary angioplasty with stents. A study published in September in Mayo Clinic Proceedings says that a better option may be repeating the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 18, 2019 Category: Databases & Libraries Source Type: news

Long-Term Beta Blockers Post-CABG Questioned, Even With Low LVEF Long-Term Beta Blockers Post-CABG Questioned, Even With Low LVEF
Use of guideline-recommended meds started out high after CABG but waned over time in a registry study that, controversially, also saw no survival benefit to long-term postoperative beta blockers.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 12, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

SYNTAXES: CABG for Best 10-Year Survival in Multivessel Disease SYNTAXES: CABG for Best 10-Year Survival in Multivessel Disease
Longer-term outcome data from SYNTAX trial give a'clear mandate'to expand the role of CABG and to adopt a more cautious indication for PCI in multivessel disease, one expert says.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 4, 2019 Category: Intensive Care Tags: Cardiology News Source Type: news

Optimal Antithrombotics to Prevent Post-CABG Adverse Events Optimal Antithrombotics to Prevent Post-CABG Adverse Events
Is ticagrelor monotherapy better than long-term aspirin in reducing major adverse cardiovascular events following coronary artery bypass grafting?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 4, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Heart Surgery Long-Term Mortality Rate Higher for Women Heart Surgery Long-Term Mortality Rate Higher for Women
Women have worse long-term mortality after coronary-artery bypass grafting (CABG) and combined CABG/mitral-valve surgery, while mortality risk factors are different for men and women, according to new findings.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 3, 2019 Category: Surgery Tags: General Surgery News Source Type: news

AFIRE Backs Less Antiplatelet Use With NOAC in AF, Stable CAD AFIRE Backs Less Antiplatelet Use With NOAC in AF, Stable CAD
Helping buttress a thin evidence base, the randomized trial argues against pairing a novel oral anticoagulant with an antiplatelet in stable CAD with AF, barring PCI or CABG in the last year.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 3, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

ODYSSEY Outcomes: High-risk Patients Benefit More From PCSK9s ODYSSEY Outcomes: High-risk Patients Benefit More From PCSK9s
Two ODYSSEY Outcomes subgroup analyses shed light on the benefits of PCSK9 inhibition in patients with polyvascular disease and previous CABG.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 27, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

No Survival Benefit with Myocardial Viability After CABG: STICH No Survival Benefit with Myocardial Viability After CABG: STICH
This study found no long-term survival benefit but modest improvement in ejection fraction.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 22, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Higher Mortality With Off-Pump CABG in Left Main Disease Higher Mortality With Off-Pump CABG in Left Main Disease
Post hoc analysis from the EXCEL trial indicates off-pump surgery was associated with increased 3-year all-cause death and more incomplete revascularization than on-pump in left main disease.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 8, 2019 Category: Intensive Care Tags: Cardiology News Source Type: news

MDX Viewer Detects Early Warning Signs in Brain Oxygenation During Cardiovascular Surgeries
Patients who undergo open heart surgeries sometimes suffer from post-operative cognitive dysfunction (POCD), which could be caused by lack of oxygen to the brain while under anesthesia. Of the roughly 500,000 patients receiving coronary artery bypass grafting procedures each year, 14–48 percent can be affected with this condition, according to David Platt, PhD, CEO of MDX Life Sciences. If the anesthesiologist notices when a patient’s brain is becoming hypoxic during surgery, steps can be taken to restore oxygen flow. However, detecting that the brain is not receiving enough oxygen is no...
Source: MDDI - July 18, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Cardiovascular Source Type: news

Google Doodle Honors Heart Surgeon Ren é Favaloro, Who Pioneered Coronary Bypass Surgery
René Favaloro, a pioneering Argentine heart surgeon, is being remembered with a Google Doodle for his contributions to coronary bypass surgery on what would have been his 96th birthday. Born in La Plata, Argentina, in 1923, Favaloro started his career as a doctor in the farming community of Jacinto Arauz, where he built his own operating room, trained nurses and set up a local blood bank. In 1962 he moved to the United States where he pioneered coronary bypass surgery, a technique used to restore blood flow to the heart when the vessel supplying it is blocked. Today, coronary artery bypass surgery is one of the mos...
Source: TIME: Health - July 12, 2019 Category: Consumer Health News Authors: Julia Webster Tags: Uncategorized Google onetime Source Type: news

TAVR Speedier Stenosis Fix Than SAVR in Patients With Prior CABG TAVR Speedier Stenosis Fix Than SAVR in Patients With Prior CABG
In patients who have previously undergone coronary-artery bypass grafting (CABG) and have symptomatic aortic stenosis (AS), transcatheter aortic-valve replacement (TAVR) using the Medtronic Corevalve System may offer advantages over surgical aortic-valve replacement (SAVR).Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 28, 2019 Category: Surgery Tags: Cardiology News Source Type: news

Experience Is Crucial in Off-Pump CABG Experience Is Crucial in Off-Pump CABG
The latest trial to evaluate long-term outcomes of on-pump vs off-pump CABG helps highlight the importance of highly specialized coronary surgical teams.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 27, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Open Heart Surgery Beats Stents for Multivessel Disease
FRIDAY, May 17, 2019 -- Coronary artery bypass graft (CABG) surgery may be a better treatment option than percutaneous coronary intervention (PCI) for most patients with more than one blocked heart artery, according to a study published online May 1... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2019 Category: Pharmaceuticals Source Type: news

Open heart surgery outperforms stents in patients with multivessel disease
(Elsevier) Coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2019 Category: International Medicine & Public Health Source Type: news

Reminder Bell Improves Incentive Spirometer Use After CABG Reminder Bell Improves Incentive Spirometer Use After CABG
Following coronary artery bypass grafting (CABG) surgery, compliance with incentive spirometer use was improved by the SpiroTimer, an add-on use tracking device that sounds a reminder bell, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 19, 2019 Category: Consumer Health News Tags: General Surgery News Source Type: news

No Survival Benefit for Volatile Anesthesia in Elective CABG Surgery No Survival Benefit for Volatile Anesthesia in Elective CABG Surgery
In a comparison of gas versus needle, a new pragmatic trial has shown that using a volatile anesthesia agent during elective coronary-artery bypass grafting (CABG) did not produce fewer deaths after one year.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 20, 2019 Category: Surgery Tags: Cardiology News Source Type: news

Volatile Anesthetics Do Not Reduce Deaths in Elective CABG
TUESDAY, March 19, 2019 -- For patients undergoing elective coronary artery bypass grafting (CABG), there is no significant difference in deaths at one year with anesthesia with a volatile agent versus total intravenous anesthesia, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2019 Category: Pharmaceuticals Source Type: news

Overlapping Surgery Largely Safe
(MedPage Today) -- But study raises questions for CABG and higher-risk patients (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 26, 2019 Category: Surgery Source Type: news

Science Saturday: The heart of art
This image is not a medical illustration. It's actually an enhanced CT scan that is as aesthetic as it is instructive. The patient had previously undergone coronary artery bypass surgery. You can see the connection points of the grafts to the aorta. Clips and wires used by the surgeon are also visible. The bypass grafts [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 9, 2019 Category: Databases & Libraries Source Type: news

AtriCure launches CryoIce persistent AF ablation trial
AtriCure (NSDQ:ATRC) said today that it launched a new FDA investigational device exemption cleared trial of its CryoIce system exploring its use in treating persistent atrial fibrillation during concomitant open-chested cardiac surgery. The first patient in the trial has already been treated, the Mason, Ohio-based company said. The initial procedure took place at Takoma Park, Md.’s Washington Adventist Hospital. “Cryothermal energy has been a mainstay of surgical ablation for a long time. The ICE-AFIB IDE trial is the first of its kind designed to assess the safety and sustained effectiveness of cryotherm...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials Surgical AtriCure Inc. Source Type: news

Post-CABG On-Table Extubation Tied to Less Hospital Time
(MedPage Today) -- Average length of stay was 5.6 days for OTE patients (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - January 31, 2019 Category: Surgery Source Type: news

Death at 10 Years Similar With Bilateral-, Single-Artery CABG
WEDNESDAY, Jan. 30, 2019 -- There is no difference in the rate of death from any cause at 10 years for patients undergoing coronary artery bypass grafting (CABG) with bilateral or single internal-thoracic-artery grafting, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2019 Category: Pharmaceuticals Source Type: news

Post-CABG PCI Tied to Worse Outcomes, Higher Cost
(MedPage Today) -- Death rate of 5.1% in PCI patients exceeded 2.7% rate in those who did not require PCI (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 28, 2019 Category: Cardiology Source Type: news

Rivaroxaban Might Not Add Much to Post-CABG Prevention
(MedPage Today) -- Nonsignificant signal for fewer MACE seen in COMPASS substudy (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 15, 2019 Category: Cardiology Source Type: news

Not Just Acid Reflux: The Need to Think Worst First
A previously healthy, well-appearing 42-year-old female living in a modern, high-rise apartment in downtown Los Angeles calls 9-1-1 at 5:30 am complaining of worsening of a burning, epigastric pain she had been experiencing for the last three days. She reports associated nausea and non-bloody, non-bilious vomiting, and that she couldn’t manage to get comfortable in bed until she finally decided to call for help at daybreak. During her 9-1-1 call, she reports “pain, like heartburn, that just woke me up again and I had to throw up, … and then I was sweating so much.” Using the Los Angeles Tiered Disp...
Source: JEMS Special Topics - January 13, 2019 Category: Emergency Medicine Authors: Stephen Sanko, MD, FACEP Tags: Exclusive Articles Cardiac & Resuscitation Source Type: news

Villafa ña-led vascular dev Medical 21 registers for $21m offering
St. Jude Medical founder Manny Villafaña’s newest medical play, Medical 21, has registered for an upcoming $10 million equity offering, according to a recently posted SEC filing. The company, which was unveiled in late 2017, is developing an artificial blood vessel as an alternative to harvesting blood vessels for coronary artery bypass surgeries, and has already begun animal testing of the technology. Medical 21 is using a new material developed by the University of Iowa and licensed to the company to make its artificial vessels. The material consists of cellulose graft conduits supported by a thin nitinol wi...
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Wall Street Beat medical21 Source Type: news

Cardiovascular Care Better at Top-Ranked Hospitals Cardiovascular Care Better at Top-Ranked Hospitals
The US News& World Report's'Best Hospitals'for cardiology provide better care for acute MI, heart failure, and coronary artery bypass surgery than nonranked hospitals, a new analysis confirms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

FFR for CABG; Botox Arrhythmia Prevention; Med Device Investigations
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 3, 2018 Category: Urology & Nephrology Source Type: news

FARGO: No Gain With FFR Over Angiography in Multivessel CABG FARGO: No Gain With FFR Over Angiography in Multivessel CABG
While acknowledging the study's limitations, observers say'the lessons learned from the FFR trials in PCI may not be extrapolated to CABG patients. 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 30, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Even at 8 Years, CABG Bests PCI in Diabetes: FREEDOM Extended Even at 8 Years, CABG Bests PCI in Diabetes: FREEDOM Extended
With follow-up time doubled since FREEDOM was reported in 2012, a new analysis suggests the CABG advantage in diabetics with multivessel disease is durable; especially, it hints, in several subgroups.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

TiCAB: Ticagrelor No Better Than Aspirin 1-Year Post-CABG TiCAB: Ticagrelor No Better Than Aspirin 1-Year Post-CABG
Although hopes for further ticagrelor monotherapy trials after bypass surgery have been squashed, larger dual-antiplatelet therapy outcomes trials are warranted.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 27, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Omega-3 and Vitamin D; Vein Grafts and CABG: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include benefits of CABG, vein harvesting, new exercise guidelines, and omega-3 and vitamin D supplementation (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - November 17, 2018 Category: Neurology Source Type: news

AHA: Lasting Benefit for CABG in Diabetes, Multivessel Disease
THURSDAY, Nov. 15, 2018 -- For patients with diabetes mellitus (DM) with multivessel coronary disease (MVD), coronary revascularization with coronary artery bypass grafting (CABG) is associated with lower all-cause mortality than percutaneous... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 15, 2018 Category: Pharmaceuticals Source Type: news

Bypass Beats Stents in Diabetes With Heart Trouble
People with diabetes who have coronary-artery bypass surgery survive about three years longer than those who have their blood vessels propped open with stents, new research shows. (Source: WebMD Health)
Source: WebMD Health - November 13, 2018 Category: Consumer Health News Source Type: news

REGROUP Lifts Cloud Over Endoscopic Vein Harvesting for CABG REGROUP Lifts Cloud Over Endoscopic Vein Harvesting for CABG
The less invasive approach is favored by patients, but earlier trials suggested safety concerns with endoscopic vein-graft harvesting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 12, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

AHA: Post-CABG Ticagrelor No Better Than Aspirin
(MedPage Today) -- And safety no better with ticagrelor either (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 12, 2018 Category: Cardiology Source Type: news

AHA: CABG Still Better for Multivessel Disease in Diabetes
(MedPage Today) -- FREEDOM trial extension suggests lower long-term mortality vs stents (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 12, 2018 Category: Primary Care Source Type: news

AHA: Endoscopic Vein-Graft Harvesting Redeems Itself in CABG
(MedPage Today) -- Operator expertise takes care of safety concerns (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2018 Category: Cardiology Source Type: news

TCT: 10 Years On, Surgery for Left Main Disease Edges Stenting
(MedPage Today) -- Separate studies suggest some groups do better with CABG (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - September 25, 2018 Category: Surgery Source Type: news